NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-200-2021-0-US-02 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE US National Stage 18/705,869 Pending
NIAID E-066-2014-0-US-28 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US DIV 18/648,190 Pending
NCI E-209-2014-0-JP-01 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO JP DIV 2024-73035 Pending
NIBIB E-168-2021-2-CN-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy With Isotropic Spatial Resolution CN National Stage 202280072069.8 Pending
NCI E-282-2016-2-IL-03 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY IL DIV 312426 Pending
NCI E-204-2021-0-US-02 SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN US National Stage 18/704,211 Pending
NCI E-017-2017-0-US-11 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US CON 18/644,724 Pending
NCI E-068-2018-0-CN-01 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 CN DIV 202410477974.2 Pending
OD E-120-2021-0-US-02 PREDICTION OF TRANSFORMATIVE BREAKTHROUGHS IN RESEARCH US National Stage 18/703,175 Pending
NIDCR E-130-2023-0-PC-01 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS PCT PCT PCT/US2024/025390 Pending
NIDCR E-130-2023-0-TW-01 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS TW ORD 113114733 Pending
NIAID E-234-2016-1-US-05 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US CON 18/638,334 Pending
NCI E-181-2017-0-MX-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS MX DIV MX/a/2024/004610 Pending
NCI E-003-2022-0-US-02 AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING US National Stage 18/700,977 Pending
NCATS E-172-2021-0-KR-01 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES KR National Stage 10-2024-7012300 Pending
NIMH E-070-2023-0-PC-01 SYSTEMS AND METHODS FOR MULTICHANNEL INDIVIDUALIZED STIMULATION THERAPY PCT PCT PCT/US2024/023876 Pending
NCI E-053-2019-0-CN-11 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES CN DIV 202410413639.6 Pending
NHGRI E-134-2023-0-PC-01 SYNTHETIC MMAB GENES AND AAV VECTORS TO TREAT COBALAMIN B DEFICIENCY PCT PCT PCT/US2024/023432 Pending
NIAID E-160-2021-0-US-02 AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 US National Stage 18/699,057 Pending
NIA E-207-2021-0-US-02 COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE US CIP 18/627,191 Pending
NINDS E-061-2023-0-PC-01 SYSTEMS AND METHODS FOR PATTERNED MULTI-SLICE EXCITATION IN MAGNETIC RESONANCE IMAGING PCT PCT PCT/US2024/022852 Pending
NCI E-280-2016-0-US-02 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME US CON 18/623,529 Pending
NCI E-136-2023-0-PC-01 ALLOSTERIC INHIBITORS OF THE PLK1 POLO BOX DOMAIN, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER PCT PCT PCT/US2024/022328 Pending
NICHD E-151-2021-0-US-02 NUCLEAR MAGNETIC RESONANCE METHODS OF DETERMINING HOMEOSTATIC
PERTURBATIONS 		US National Stage 18/697,168 Pending
NIAID E-154-2017-0-US-05 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US CON 18/619,995 Pending
NCI E-133-2016-0-EP-12 FLT3-Specific Chimeric Antigen Receptors and Methods Using Same EP DIV 24167685.7 Pending
NCI E-169-2021-0-KR-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE KR National Stage 10-2024-7010519 Pending
NHLBI E-080-2023-0-PC-01 ENZYMATIC RADIOSYNTHESIS OF DEOXY-[18F] FLUOROCELLOBIOSE AND DEOXY-[18F]
FLUOROCELLOTRIOSE 		PCT PCT PCT/US2024/021440 Pending
NHLBI E-188-2021-0-CN-01 ANTI-CMPL DIVALENT SCFV AND USES THEREOF CN National Stage 202280065162.6 Pending
NCI E-054-2023-0-PC-01 T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53 PCT PCT PCT/US2024/021425 Pending
NIAID E-228-2016-1-KR-17 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof KR DIV 10-2024-7010062 Pending
NIAID E-270-2015-0-US-06 SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES US CON 18/615,011 Pending
NIAID E-060-2015-0-US-18 NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES US DIV 18/615,895 Pending
NCATS E-082-2021-0-EP-01 COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME EP National Stage 22873333.3 Pending
NCATS E-004-2016-0-AU-02 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF AU DIV 2024201890 Pending
NCATS E-172-2021-0-EP-01 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES EP National Stage 22782640.1 Pending
NCATS E-082-2021-0-US-02 COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME US National Stage 18/694,167 Pending
NHLBI E-146-2023-0-US-01 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF US ORD 18/610,978 Pending
NCI E-169-2021-0-EP-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE EP National Stage 22777538.4 Pending
NHLBI E-188-2021-0-IL-01 ANTI-CMPL DIVALENT SCFV AND USES THEREOF IL National Stage 311590 Pending
NEI E-131-2022-0-PCT-01 METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION PCT PCT PCT/US2024/020294 Pending
NCATS E-041-2021-3-PC-01 Combinations of Retinaldehyde Dehydrogenase 1 (RALDH1) Inhibitors and Immunostimulators and Methods Using Same PCT PCT PCT/US2024/020160 Pending
NIDCR E-094-2023-0-PCT-02 METHODS FOR PRODUCING STABLE HUMAN CHONDROCYTES AND THEIR USE PCT PCT PCT/US2024/020102 Pending
NCATS E-172-2021-0-US-02 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY
SARS-COV-2 NEUTRALIZING ANTIBODIES 		US National Stage 18/692,570 Pending
NIAID E-052-2017-4-HK-02 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection HK CN 42024088832.1 Pending
NCI E-190-2014-0-US-02 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US CON 18/605,198 Pending
NCATS E-172-2021-0-JP-01 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES JP National Stage 2024-516630 Pending
NCATS E-172-2021-0-CA-01 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES CA National Stage 3232223 Pending
NICHD E-198-2022-0-PC-01 SYSTEM AND PROTOCOL FOR MONITORING PREGNANCY HEALTH PCT PCT PCT/US2024/019168 Pending
NHLBI E-188-2021-0-EP-01 ANTI-CMPL DIVALENT SCFV AND USES THEREOF EP National Stage 22813001.9 Pending